Bill Few Associates, Inc. Edwards Lifesciences Corp Transaction History

Bill Few Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$84.3 - $94.31 $18,630 - $20,842	221 Added 9.18%	2,628 $242,000
Q1 2024 Apr 18, 2024	BUY	$72.54 - $95.56 $174,603 - $230,012	2,407 New	2,407 $230,000
Q4 2022 Jan 24, 2023	SELL	$68.3 - $87.44 $16,118 - $20,635	-236 Reduced 7.14%	3,071 $0
Q3 2022 Oct 13, 2022	SELL	$82.37 - $107.29 $9,143 - $11,909	-111 Reduced 3.25%	3,307 $273,000
Q1 2022 Apr 27, 2022	BUY	$101.96 - $128.34 $348,499 - $438,666	3,418 New	3,418 $402,000

1,341

467M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Bill Few Associates, Inc. with notifications on news.